The Helix3 team has been consistently working together since 1994 developing new methods and conducting GLP studies for regulatory submissions. We are committed to providing innovative solutions with an unmatched focus on quality, flexibility and attention to detail.
JOURNAL / BOOK CHAPTERS
Cytotoxicity and its impact on the in vivo comet assay (IWGT 2013)
Evaluating DNA reactivity with the acellular comet assay (GTA 2011)
The comet assay: Breaking from tradition (GTA 2008
Target organ selection for the in vivo comet assay: Genotoxicity vs. tumorigenesis (EMS 2008)
Safety testing with the in vitro comet assay: Critital factors in protocol design and data interpretation (EMS 2007)
The effects of sample processing on in vivo comet assay samples (EMS 2006)